Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the Lung
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Trastuzumab
Related studies linked through entity extraction aliases.
Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib
- Status
- TERMINATED
- Phase
- PHASE3
Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Treatment of Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2